HomeOpen Access NewsDiseases & Conditions

Diseases & Conditions

Largest-ever £26 million trial launches across UK to slow Parkinson’s disease

The world's largest clinical trial for Parkinson’s disease has commenced, aiming to identify treatments that can slow or halt disease progression.

Reduce risk of dementia through leisure activities

Dementia poses a risk to us all, but research shows that there are leisure activities that are scientifically proven to reduce risk of dementia.

Unusual signs and symptoms of raised cholesterol

Many people only become aware for the first time that they have a high cholesterol level, only when they are admitted to hospital with a heart attack.

Lyme disease diagnoses increased 357% in rural areas

Lyme disease diagnoses have increased 357% in rural areas and 65% in urban areas in the United States, causing national concern.

Hair loss and low libido added as symptoms of COVID-19

Hair loss and sexual dysfunction, or low libido, have been added to the long list of symptoms of COVID-19 and those with long COVID.

COVID-19 symptoms are changing with new variants

A sore throat and hoarse voice were the main COVID-19 symptoms with newer variants – but have symptoms changed as variants get smarter?

Type 1 diabetes treatment finds new target

A new route to the regeneration of insulin in the pancreatic stem cells indicates a major breakthrough for Types 1 and 2 Diabetes therapies.

Diabetes education: one in five search results for diabetes lack reliable information

Improved, reliable diabetes education is needed for both people living with diabetes and healthcare professionals.

Omicron subvariants are better at eluding vaccines

The most recent omicron subvariants have caused new infection spikes across the United States, as researchers find they are better at eluding vaccines.

ArrestAD: Exploiting the bittersweet side of Alzheimer’s disease

The Alzheimer’s disease puzzle is being completed. This is where the ArrestAD programme comes in, to exploit the bittersweet side of AD.

Disease X and other high priority diseases

According to the WHO, Disease X refers to a hypothetical, unknown pathogen that could cause a future epidemic.

Data capture for researching degenerative eye disease

Translational Imaging Innovations makes data accessible to research degenerative eye disease.

Digital biomarker predicts mild cognitive impairment conversion to Alzheimer’s

Digital biomarker can identify which cases of mild cognitive impairment will develop into Alzheimer’s so that early interventions can be put in place to prevent the onset of the disease.

Regenerative therapies for multiple sclerosis: Clues from studying normal brain development

Tara M. DeSilva from the Department of Neurosciences, Cleveland Clinic, walks us through regenerative therapies for multiple sclerosis, including comment on clues from studying normal brain development.

JPND: Towards a stronger brain health partnership

One of JPND’s key objectives is to fortify its work in brain health partnerships in Europe to better combat the challenges of neurodegenerative disease (ND).

What is vasovagal syncope and why do some people faint in the sun?

Vasovagal syncope is when a person suddenly loses consciousness and faints as a result of overheating, emotional distress, or even the sight of blood.

Lager beer can lessen risk of disease in men’s gut microbes

Both alcoholic and non-alcoholic lager beer drank in moderation can improve gut microbes in men ­– lessening the chances of developing chronic diseases.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders